AFLD 2012 FFL vs Respondent M73

Facts
The French Wrestling Federation (Fédération Française de Lutte, FFL) charges respondent M73 for a violaton of the Anti-Doping Rules. During a match on November 19, 2011, a sample was taken for doping control purposes. The analysis of the sample showed the presence of prednisolone and prednisone. Prednisolone and prednisone are prohibited substances according the World Anti-Doping Agency (WADA) prohibited list and regarded as specified substances.

History
The respondent claimed he used medication or therapeutic purposes
to treat asthma. He has a certificate of his physician and some medical investigations.

Decision
1. The decision dated February 24, 2012, of the disciplinary committee of the FFL is cancelled.
2. The respondent is acquitted.
3. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
27 September 2012
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acquittal
Sport/IFs
Wrestling (UWW) - United World Wrestling
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Lutte (FFL) - French Wrestling Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S9. Glucocorticosteroids
Substances
Prednisolone
Prednisone
Medical terms
Asthma
Legitimate Medical Treatment
Document type
Pdf file
Date generated
24 March 2014
Date of last modification
25 March 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin